The future won’t be mined, 
extracted, wired or launched.

It will be grown.

The future won’t be mined, extracted, wired or launched.

It will be grown.

We incubate, fund and launch new companies
that use programmed biology to shape the human future.
The Ferment Co is a company creation studio for the next wave of synthetic biology product companies. We’re powered by Ginkgo Bioworks, the world’s most advanced platform for cell programming.
Ferment Co matches visionary Founders —
technical and non-technical alike — with world-class resources for building with biology.
New ideas don’t have to wait.
Projects that used to require massive technical resources, infrastructure, and timelines can now launch almost overnight, with Ginkgo as the technical backend.
Ferment Co works with Founders to start first-ever companies operating with new business models and growth trajectories. Incredible capabilities are now available to anyone who wants to build with biology.

We incubate, fund and launch new companies

that use programmed biology
to shape the human future.

The Ferment Co is a company creation studio for the next wave of synthetic biology product companies. We’re powered by Ginkgo Bioworks, the world’s most advanced platform for cell programming.

Ferment Co matches visionary Founders —
technical and non-technical alike — with world-class resources for building with biology.

New ideas don’t have to wait.
Projects that used to require massive technical resources, infrastructure, and timelines can now launch almost overnight, with Ginkgo as the technical backend.

Ferment Co works with Founders to start first-ever companies operating with new business models and growth trajectories. Incredible capabilities are now available to anyone who wants to build with biology.

Biotechnology
is not just for engineering new medicines.
From electronics to waste remediation, aquaculture to infant nutrition, flavor creation to cannabinoids, innovators are shifting to biology.

The cell is the new microchip and the new factory. It contains both the instructions and the machinery for producing an endless number of useful compounds and materials.

The DNA inside of every living cell is a form of programmable code. This code is the universe’s most efficient way to organize information, energy, and matter into physical fabrication systems.

Biology itself is a
manufacturing technology.
Developing it with care creates endless opportunities to improve human welfare.
Programmable biology is the future of food, pharma, farming. Of design and manufacturing.
Of everything.
“The interesting thing to program in the 21st century isn’t computers —
it's biology! "

Meet Our Team

Jason Kakoyiannis

Managing Partner

Brian Brazeau

Partner
Jason Kakoyiannis
Managing Partner

Jason Kakoyiannis founded Ferment Co in 2021 as the vehicle to create the next wave of synthetic biology product companies. Specifically, these are companies born platform native on top of Foundries like the ones at Ginkgo Bioworks. In the age of “bio Foundries,” biotech company creation looks different because Founders can take immediate advantage of ready hardware infrastructure, pre-packed cell development kits, debugged biological code assets, and other economies of scale.

Jason joined forces with Ginkgo Bioworks in 2015 as part of the commercial team. From 2018 – 2021, he was Head of Ventures, where he helped found strategic spinoff companies like Motif Foodworks (food ingredients), Allonnia (waste remediation), Arcaea (personal care and beauty actives), Verb Biotics (probiotics for consumer nutrition), and Ayana Bio (plant bioactives for complementary medicine).

Prior to joining forces with Ginkgo, Jason held strategic growth roles at Givaudan developing global products and brands with Unilever, Natura, Estée Lauder, and others. He began his career as an M&A attorney at Shearman & Sterling in public company transactions and takeover defense. Jason received his BA from Brown University, MA from Yale, and JD from USC.

Brian Brazeau
Partner

Brian believes that biotechnology is a critical enabler in developing solutions to some of the grand challenges we face on our path towards a more sustainable future. He has focused his entire career on understanding different parts of the value chain in industrial, food, and agricultural applications of biotechnology.

Prior to joining Ferment, Brian was the President of North America for Novozymes where he oversaw a broad range of businesses. Previous to his work at Novozymes, Brian worked in R&D, manufacturing, and commercial roles at Cargill and DSM. From 2016-2017, Brian worked at Ginkgo Bioworks where he was General Manager of the Enzymes business.

Brian has a PhD in Biochemistry from the University of Minnesota.

Incredible capabilities are now available to anyone who wants to build with biology.
If you have a company idea that you think we should know about, we’d love to hear from you. Start here.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We have the capacity to create everything we need to flourish -- from food to medicine to new materials. As we adapt biology to meet human needs, there’s a universe still to be discovered.
Let’s grow a new world together.
Terms & ConditionsPrivacy Policy
© Copyright 2021 Ferment. All rights reserved. Images Created by Tal Danino Studio.

Biotechnology
is not just for engineering new medicines.

From electronics to waste remediation, aquaculture to infant nutrition, flavor creation to cannabinoids, the site of innovation is shifting to biology.

The cell is the new microchip and the new factory. It contains both the instructions and the machinery for producing an endless number of useful compounds and materials.

The DNA inside of every living cell is a form of programmable code. This code is the universe’s most efficient way to organize information, energy, and matter into physical fabrication systems.

Biology itself is a manufacturing technology. Developing it with care
creates endless opportunities to
improve human welfare.

Tal Danino Studio
Twenty years ago, synthetic biology was only a conversation between PhDs. As scientists applied engineering principles to molecular biology, a new discipline was born.

Ten years ago, large-scale DNA synthesis marked a new achievement: the creation of the first synthetic genomes.

Since then, Ginkgo’s has made profound advances in synthesizing biology, and our pace of discovery is accelerating. Gingko has created a new space for conducting genome design with automated instrumentation that allows for ultra high-throughput build / test cycles. There’s nowhere else like it.

Programmable biology is the future of food, pharma, farming. Of design and manufacturing. Of everything.

“The interesting thing to program in the 21st century isn’t computers —
its biology."

The tools to work with biology in a predictive way are rapidly evolving, and Ginkgo’s platform serves as the interface layer to make these capabilities available to anyone who wants to build with biology.

Tom Knight, Ginkgo Bioworks

Meet Our Team

Jason Kakoyiannis

Managing Partner

Brian Brazeau

Partner

Jason Kakoyiannis

Managing Partner

Jason Kakoyiannis founded Ferment.Co in 2021 as the vehicle to create the next wave of synthetic biology product companies. Specifically, these are companies born platform native on top of Foundries like the ones at Ginkgo Bioworks. In the age of “bio Foundries,” biotech company creation looks different because Founders can take immediate advantage of ready hardware infrastructure, pre-packed cell development kits, debugged biological code assets, and other economies of scale.

Jason joined forces with Ginkgo Bioworks in 2015 as part of the commercial team. From 2018 – 2021 he was Head of Ventures, where he helped found strategic spinoff companies like Motif Foodworks (food ingredients), Allonnia (waste remediation), Arcaea (personal care and beauty actives), Verb Biotics (probiotics for consumer nutrition), and Ayana Bio (plant bioactives for complementary medicine).

Prior to joining forces with Ginkgo, Jason held strategic growth roles at Givaudan developing global products and brands with Unilever, Natura, Estée Lauder, and others. He began his career as an M&A attorney at Shearman & Sterling in public company transactions and takeover defense. Jason received his BA from Brown University, MA from Yale, and JD from USC.

Brian Brazeau

Partner

Brian believes that biotechnology is a critical enabler in developing solutions to some of the grand challenges we face on our path towards a more sustainable future. He has focused his entire career on understanding different parts of the value chain in industrial, food, and agricultural applications of biotechnology.

Prior to joining Ferment, Brian was the President of North America for Novozymes where he oversaw a broad range of businesses. Previous to his work at Novozymes, Brian worked in R&D, manufacturing, and commercial roles at Cargill and DSM. From 2016-2017, Brian worked at Ginkgo Bioworks where he was General Manager of the Enzymes business.

Brian has a PhD in Biochemistry from the University of Minnesota.

Brian Brazeau

Partner

Brian believes that biotechnology is a critical enabler in developing solutions to some of the grand challenges we face on our path towards a more sustainable future. He has focused his entire career on understanding different parts of the value chain in industrial, food, and agricultural applications of biotechnology.

Prior to joining Ferment, Brian was the President of North America for Novozymes where he oversaw a broad range of businesses. Previous to his work at Novozymes, Brian worked in R&D, manufacturing, and commercial roles at Cargill and DSM. From 2016-2017, Brian worked at Ginkgo Bioworks where he was General Manager of the Enzymes business.

Brian has a PhD in Biochemistry from the University of Minnesota.

Jason Kakoyiannis

Managing Partner

Jason Kakoyiannis founded Ferment.Co in 2021 as the vehicle to create the next wave of synthetic biology product companies. Specifically, these are companies born platform native on top of Foundries like the ones at Ginkgo Bioworks. In the age of “bio Foundries,” biotech company creation looks different because Founders can take immediate advantage of ready hardware infrastructure, pre-packed cell development kits, debugged biological code assets, and other economies of scale.

Jason joined forces with Ginkgo Bioworks in 2015 as part of the commercial team. From 2018 – 2021 he was Head of Ventures, where he helped found strategic spinoff companies like Motif Foodworks (food ingredients), Allonnia (waste remediation), Arcaea (personal care and beauty actives), Verb Biotics (probiotics for consumer nutrition), and Ayana Bio (plant bioactives for complementary medicine).

Prior to joining forces with Ginkgo, Jason held strategic growth roles at Givaudan developing global products and brands with Unilever, Natura, Estée Lauder, and others. He began his career as an M&A attorney at Shearman & Sterling in public company transactions and takeover defense. Jason received his BA from Brown University, MA from Yale, and JD from USC.


Incredible capabilities are now available to anyone who wants to build with biology.

If you have a company idea that you think we should  know about, we’d love to hear from you. Start here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.